IP Library Granted Patent US 8,322,348
Granted Patent B2
US 8,322,348 · App. 12/947,310 · Granted Dec 4, 2012

Methods and systems for laser treatment using non-uniform output beam

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,322,348
App. No.
12/947,310
Granted
Dec 4, 2012
Kind
B2
Abstract

Methods and apparatus for treatment, such as skin rejuvenation treatment, using non-uniform laser radiation. An output beam from a laser source is coupled into an optical system that modifies the beam to provide a large-diameter beam having a non-uniform energy profile, comprised of a plurality of high-intensity zones surrounded by lower-intensity zones within the treatment beam. A large area of tissue, preferably 7-10 mm in diameter, can be treated simultaneously, while minimizing the risk of burning or other damage to the skin.

Claims (25)

1. A method for treating human tissue, comprising:

generating an output beam from a laser source;

coupling the beam into an optical system that modifies the beam to provide a treatment beam having a non-uniform energy profile, said non-uniform energy profile being comprised of regions of relatively high energy per unit area within a substantially uniform background region of relatively low energy per unit area in comparison to the regions of relatively high energy per unit area; and

directing the treatment beam to a target tissue such that the regions of relatively high energy per unit area of the beam illuminate portions of the target tissue and deliver sufficient energy to such portions of the target tissue to heat such portions of the target tissue to a first temperature T 1 , and wherein the substantially uniform background region of relatively low energy per unit area of the beam illuminates the remaining portion of the target tissue and delivers sufficient energy to such remaining portion of the target tissue to heat the remaining portion of the target tissue to a second temperature T 2 , wherein T 2 is less than T 1 .

2. The method of claim 1 , wherein the treatment beam regions of relatively high energy per unit area heat select portions of the target tissue to a first temperature T 1 of 35 degrees C. or higher.

3. The method of claim 1 , wherein the laser source comprises an Nd:YAG laser or a diode laser.

4. The method of claim 1 , wherein the wavelength of the output beam is between about 1.3 microns and 1.6 microns.

5. The method of claim 4 , wherein the wavelength of the output beam is between about 1.40 and 1.44 microns.

6. The method of claim 1 , wherein the treatment beam at the target tissue area has a diameter between about 5 and 10 mm.

7. The method of claim 6 , wherein the average fluence of the treatment beam at the target tissue area is less than about 10 J/cm2.

8. The method of claim 1 , wherein the output beam has a pulse duration of between 0.1 and 100 milliseconds.

9. The method of claim 8 , wherein the output beam has a pulse duration of between 20 and 80 milliseconds.

10. The method of claim 1 , wherein the optical system comprises a fiber bundle.

11. The method of claim 10 , wherein the fiber bundle comprises 1000 to 2000 fibers.

12. The method of claim 10 , wherein the optical system comprises a focusing lens for coupling the output beam into a proximal end of the fiber bundle, and an optical window between the distal end of the fiber bundle and the target tissue, the optical window permitting the beam emitted from each fiber in the bundle to diverge before it reaches the target skin so that each beam partially overlaps with the beam(s) from adjacent fibers in the bundle.

13. The method of claim 12 , wherein the optical window is between 1 and 5 mm thick.

14. The method of claim 10 , wherein the average fluence of the treatment beam is less than about 10 J/cm2.

15. The method of claim 10 , wherein the optical system comprises a transport fiber that carries the output pulse from the laser source to a handpiece containing the fiber bundle.

16. The method of claim 1 , wherein the optical system comprises a diffractive lens array such that each lens in the array provides a region of relatively high energy per unit area, the regions of relatively high energy per unit area within a substantially uniform background region of relatively low energy per unit area in comparison to the regions of relatively high energy per unit area.

17. The method of claim 16 , wherein the diffractive lens array comprises about 2000 or less lenses in the array.

18. The method of claim 17 , wherein each lens is between about 150 and 1000 microns in diameter.

19. The method of claim 16 , wherein the diffractive lens array is between 5 and 10 millimeters in diameter.

20. The method of claim 16 , wherein the average fluence of the laser output beam is less than about 10 J/cm2.

21. The method of claim 16 , wherein the output beam has a pulse duration between 0.1 and 100 milliseconds.

22. The method of claim 21 , wherein the output beam has a pulse duration between 20 and 80 milliseconds.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 1, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066723/0227 →
TERMINATION AND RELEASE OF PATENTS Recorded Feb 29, 2024
From: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
To: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 066707/0957 →
ABL NOTICE AND CONFIRMATION OF GRANT OFSECURITY INTEREST IN PATENTS Recorded Jan 12, 2024
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 066222/0937 →
NOTICE AND CONFIRMATION OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2020
From: CYNOSURE, LLC; PALOMAR MEDICAL TECHNOLOGIES, LLC
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051496/0579 →
RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Dec 30, 2019
From: BANK OF AMERICA, N.A.
To: CYNOSURE, LLC
Reel/Frame 051447/0536 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →
CHANGE OF NAME Recorded Mar 22, 2019
From: CYNOSURE, INC.
To: CYNOSURE, LLC
Reel/Frame 048678/0928 →